You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

"Multiple Myeloma"
Topics

Advertisement

Advertisement

"Multiple Myeloma"

Showing articles that match "Multiple Myeloma" in the headline

Yesterday

BMS eyes role for new CAR-T in post-BCMA multiple myeloma pharmaphorum 13:25 Wed, 09 Sep

Bristol Myers Squibb Reports Positive Phase 2 Results For Arlo-cel In Multiple Myeloma RTT News 10:05 Wed, 09 Sep

Tuesday

Navigating Empathy, Burnout, and Long-Term Relationships in Multiple Myeloma Medpage Today 20:24 Tue, 08 Sep

Advertisement

Advertisement

Genomic Profiling and MRD Testing Refine Risk Stratification in Multiple Myeloma Hematology Advisor 15:09 Tue, 08 Sep

Medicaid Coverage, Race Linked to ASCT Rates in Newly Diagnosed Multiple Myeloma Oncology Nurse Advisor 14:24 Tue, 08 Sep

Friday

ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study Zacks 17:02 Fri, 04 Sep

AbbVie Reports Positive Phase 3 Results For Etentamig In Multiple Myeloma RTT News 02:50 Fri, 04 Sep

In the last month

AbbVie Touts Positive Data For Multiple Myeloma Drug Benzinga 19:13 Thu, 03 Sep

AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma AbbVie (Press Release) 14:25 Thu, 03 Sep

AI cuts multiple myeloma trial screening from 2 weeks to seconds Korea Biomedical Review 07:56 Wed, 02 Sep

First patient dosed in KOALA CAR-T trial for multiple myeloma Pharmaceutical Field 12:24 Tue, 01 Sep

Optimized EAP regimen delivers outstanding mobilization effects in multiple myeloma and lymphoma patients News-Medical.Net 17:09 Thu, 27 Aug

European Commission approves teclistamab plus daratumumab for relapsed/refractory multiple myeloma, offering a... ecancer 16:17 Tue, 25 Aug

Protein degrader approval offers hope to relapsed multiple myeloma patients Chemistry World Magazine 09:29 Tue, 25 Aug

Johnson & Johnson’s multiple myeloma treatment secures EC approval Pharmaceutical Technology 10:06 Mon, 24 Aug

Blenrep clears 1st reimbursement hurdle in Korea for relapsed multiple myeloma Korea Biomedical Review 05:56 Thu, 20 Aug

Hematogenix's Mm Mrd Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's Zenbexus™, the First Approved CELMoD Therapy for Multiple Myeloma PR Newswire (Press Release) 13:40 Wed, 19 Aug

Advertisement

Zenbexus Granted Accelerated Approval in Relapsed or Refractory Multiple Myeloma Hematology Advisor 15:35 Mon, 17 Aug

Impact of socioeconomic status on treatment and survival in multiple myeloma in Australia Nature.com 01:22 Sat, 15 Aug

Hematogenix's Proprietary MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma PRWeb (Press Release) 23:30 Fri, 14 Aug

BMS wins FDA accelerated approval for multiple myeloma therapy BioWorld 18:52 Fri, 14 Aug

BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod FiercePharma 15:18 Fri, 14 Aug

STAT Plus: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class STAT 13:07 Fri, 14 Aug

BMS secures FDA accelerated approval for Zenbexus in multiple myeloma Pharmaceutical Business Review 10:44 Fri, 14 Aug

FDA Approves First CELMoD Drug for Multiple Myeloma Medpage Today 22:41 Thu, 13 Aug

[Interview] ‘Multiple myeloma is nearing the era of cure -- but Korea needs better drugs earlier’ Korea Biomedical Review 06:15 Wed, 12 Aug

Establishment and characterization of multiple myeloma cell lines from a single patient’s disease course immortalizes clonal heterogeneity Nature.com 01:29 Wed, 12 Aug

SFDA becomes first regulatory authority globally to approve registration of 'ZENBEXUS' to treat multiple myeloma in adults Saudi Gazette 22:24 Tue, 11 Aug

Advertisement

Advertisement

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
US US
Politics Politics
World World
Sports Sports
Business Business
Cryptocurrencies
Entertainment
Lifestyle Lifestyle
AI AI
Tech Tech
Science Science